Advanced search
Publication Cover
Clinical and Experimental Hypertension Volume 29, 2007 - Issue 8
Submit an article Journal homepage
95
Views
16
CrossRef citations to date
0
Altmetric
Original

Persistence on Treatment and Blood Pressure Control with Different First-Line Antihypertensive Treatments: A Prospective Evaluation

Maria Grazia Prandin “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
,
Arrigo F.G. Cicero “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
,
Maddalena Veronesi “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
,
Eugenio Cosentino “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
,
Ada Dormi “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
,
Enrico Strocchi “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
&
Claudio Borghi “D. Campanacci” Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, ItalyCorrespondence[email protected]
 show all
Pages 553-562 | Received 17 Jul 2007, Accepted 24 Jul 2007, Published online: 03 Jul 2009

References

  • JNC VII. The Seven Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252
  • Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: An update including the 2003–2004 secondary prevention trials. Hypert Res 2005; 28(5)385–407
  • Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. J Am Med Assoc 1997; 277: 739–745
  • Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43(1)10–17
  • Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B. ESH-ESC guidelines for the management of hypertension. Herz 2006; 31(4)331–338
  • McCombs IS, Nichol MB, Newman CM, Sclar DA. The costs or interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994; 32: 214–226
  • Fujita T, Shimamoto K, Wu Z, Zhu J, Chung NS, Park JB, Lee YT, Liau CS, Chen MF. What are the major challenges in getting patients to the optimal BP goal? Difficulties in educating doctors and patients. Int J Clin Pract Suppl 2006; 150: 20–22
  • David DS. Compliance with hypertensive therapy. Hypertension 2006; 48(4)E16
  • Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: Results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypert 2000; 18(11)1691–1699
  • SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264
  • Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects or initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population based study in the elderly. Am J Hypert 1997; 10: 697–704
  • Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI. Patterns or antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clin Ther 1997; 19: 1433–1444
  • Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation or and changes in treatment after start or new courses or antihypertensive drugs: A study or a United Kingdom population. Brit Med J 1995; 311: 293–295
  • Blooms BS. Continuation of initial antihypertensive medication after one year of therapy. Clin Ther 1998; 20(4)671–681
  • Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005; 39(9)1401–1408
  • Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De Ponti F, Montanaro N. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005; 61(8)603–609
  • Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes. Am J Hypert 2002; 15(7 Pt 2)94S–97S
  • ESH-ESC. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypert 2003; 21: 1011–1053
  • Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: The SHEP pilot study. J Gerontol 1987; 42: 552–557
  • Grimm RH, Jr, Grandits GA, Cutler JA, Stewart AL, McDonald RH, Svendsen K, Prineas RJ, Liebson PR. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997; 157(6)638–648
  • Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag 2005; 1: 173–182
  • Bang LM, Chapman TM, Goa KL. Lercanidipine: A review of its efficacy in the management of hypertension. Drugs 2003; 63(22)2449–2472
  • Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E. Brisighella Heart Study Working Party. Trends in blood pressure control and antihypertensive treatment in clinical practice: The Brisighella Heart Study. J Hypert 2004; 22(9)1707–1716

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.